About McKesson Corporation
McKesson Corporation (MCK) is a Industrials company in the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry with a market capitalisation of $105.2B. The stock trades at 24.22x trailing earnings and yields 0.42%.
- Sector
- Industrials
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- Market cap
- $105.2B
- P/E ratio
- 24.22
- Forward P/E
- 17.90
- EPS (TTM)
- $37.26
- Revenue (TTM)
- $411B
- Free cash flow
- $6.8B
- Profit margin
- 1.1%
- Dividend yield
- 0.42%
- Beta
- 0.31
- Shares outstanding
- 116.6M
Financial health: Weak4.5/10
4 strengths, 5 concerns. Weakest points: current ratio, return on equity, gross margin and 2 more.
- Debt to equity: -3.00 (Strong, benchmark < 0.5) β Debt of -3.00x equity is conservative against the 0.5x benchmark. It has been broadly flat over the last 4 years.
- Net debt vs cash flow: 0.4y (Strong, benchmark < 4 years) β Net debt of $2.6B is 0.4x annual free cash flow β under a year of cash flow to repay.
- Current ratio: 0.85 (Concern, benchmark > 1.5) β Short-term assets cover only 0.85x short-term liabilities β below 1.0, meaning bills due this year exceed the assets on hand to pay them. It has been broadly flat over the last 4 years.
- Return on equity: -219.2% (Concern, benchmark > 15%) β Earns -219.2% on shareholder equity, well short of the > 15% mark.
- Gross margin: 3.6% (Concern, benchmark > 40%) β Keeps 3.6% of revenue after the direct cost of sales, well short of the > 40% mark.
- Net margin: 1.1% (Concern, benchmark > 10%) β Turns 1.1% of revenue into profit, well short of the > 10% mark.
- Free cash flow: $5.7B (Strong, benchmark positive) β Generated $5.7B of free cash flow after capital spending. It has improved over the last 4 years.
- Revenue growth: 7.7% (Watch, benchmark > 10%) β Revenue changed 7.7% year on year, short of the > 10% mark.
- Earnings growth: -17.6% (Concern, benchmark > 10%) β Earnings changed -17.6% year on year, well short of the > 10% mark.
- PEG ratio: 1.66 (Watch, benchmark < 1) β At 1.66, the price looks fair relative to expected growth β Lynch treated 1.0 as fair value.
- Payout ratio: 8.8% (Strong, benchmark < 60%) β Pays out 8.8% of earnings as dividends, leaving room to keep paying.